Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 56,888 | 41,935 | 53,567 | 61,253 | 55,392 |
| Operating Income | -56,888 | -41,935 | -53,567 | -61,253 | -55,392 |
| Other Income | 45,705 | 5,218 | 8,779 | 4,958 | -13,618 |
| Pre-tax Income | -11,183 | -36,717 | -44,788 | -56,295 | -69,010 |
| Income Tax | N/A | N/A | -15 | 1 | 18 |
| Net Income Continuous | -11,183 | -36,717 | -44,773 | -56,296 | -69,028 |
| Net Income | $-11,183 | $-36,717 | $-44,773 | $-56,296 | $-69,028 |
| EPS Basic Total Ops | -0.15 | -0.49 | -0.60 | -2.05 | -1.06 |
| EPS Basic Continuous Ops | -0.19 | -0.61 | -0.74 | -1.01 | -1.36 |
| EPS Diluted Total Ops | -0.15 | -0.49 | -0.60 | -2.05 | -1.06 |
| EPS Diluted Continuous Ops | -0.19 | -0.61 | -0.74 | -1.01 | -1.36 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.49 | -0.74 | -0.81 | -1.36 |
| EBITDA(a) | $-56,888 | $-41,935 | $-53,567 | $-61,253 | $-55,392 |